James McAvinn - Milestone Scientific Senior Vice President - Sales & Marketing
| MLSS Stock | USD 0.77 0.06 8.45% |
President
Mr. James McAvinn serves as Senior Vice President Sales Marketing of the Company. Mr. McAvinn brings over 35 years of experience in the healthcare industry including a variety of senior management, consulting, product management and marketing positions. Most recently, he served as a principal of MRA Consulting, where he served as a strategic advisor to leading pharmaceutical, medical device and OEM suppliers. From 2013 to 2016, he served as Managing Director of Product Management for 3si Surgical Safety Solutions, where he drove product strategy and execution in global surgical and interventional markets. He has also held senior executive roles at Macquet Cardiovascular, The Nova Group, MD Analytics Group, Boston Scientific Corporationration, Meadox Medicals, and Baxter Healthcare Corporationration He holds four U.S patents for medical and surgical devices since 2016.
| Tenure | 8 years |
| Professional Marks | MBA |
| Address | 425 Eagle Rock Avenue, Roseland, NJ, United States, 07068 |
| Phone | 973 535 2717 |
| Web | https://www.milestonescientific.com |
Milestone Scientific Management Efficiency
The company has return on total asset (ROA) of (0.3634) % which means that it has lost $0.3634 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.594) %, meaning that it created substantial loss on money invested by shareholders. Milestone Scientific's management efficiency ratios could be used to measure how well Milestone Scientific manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.65 in 2024. Return On Capital Employed is likely to drop to -0.9 in 2024. At this time, Milestone Scientific's Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 19.4 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 548.2 K in 2024.Similar Executives
| Found 4 records | PRESIDENT Age | ||
| Michele Larios | Retractable Technologies | 58 | |
| Dennis CPA | PAVmed Inc | 67 | |
| Russell Kuhlman | Retractable Technologies | 70 | |
| John Fort | Retractable Technologies | 50 | |
Management Performance
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.36 |
Milestone Scientific Leadership Team
Elected by the shareholders, the Milestone Scientific's board of directors comprises two types of representatives: Milestone Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Milestone. The board's role is to monitor Milestone Scientific's management team and ensure that shareholders' interests are well served. Milestone Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Milestone Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James JD, Senior Development | ||
| Jan Haverhals, CEO President | ||
| James McAvinn, Senior Vice President - Sales & Marketing | ||
| Leonard Osser, CEO and Director | ||
| Andy Molnar, Senior Dental | ||
| Keisha Harcum, Controller |
Milestone Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Milestone Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.36 | ||||
| Profit Margin | (0.55) % | ||||
| Operating Margin | (0.96) % | ||||
| Current Valuation | 48.35 M | ||||
| Shares Outstanding | 77.89 M | ||||
| Shares Owned By Insiders | 15.50 % | ||||
| Shares Owned By Institutions | 5.40 % | ||||
| Number Of Shares Shorted | 113.24 K | ||||
| Price To Earning | (6.39) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.